Costas, L
Infante-Rivard, C
Zock, J-P
Van Tongeren, M
Boffetta, P
Cusson, A
Robles, C
Casabonne, D
Benavente, Y
Becker, N
Brennan, P
Foretova, L
Maynadié, M
Staines, A
Nieters, A
Cocco, P
de Sanjosé, S
Article History
Received: 25 September 2014
Revised: 2 January 2015
Accepted: 27 January 2015
First Online: 5 March 2015
Competing interests
: PB provided expert testimony and consulted with government and private organizations on lymphoma risk and exposure to potential endocrine disruptors, including solvents and PCB. The remaining authors declared no conflict of interest.